These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1899162)

  • 21. Separation of graft-vs.-host disease and graft-vs.-leukemia effect against chronic myelogenous leukemia.
    Champlin R
    Exp Hematol; 1995 Oct; 23(11):1148-51. PubMed ID: 7556522
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse.
    Devergie A; Reiffers J; Vernant JP; Herve P; Guyotat D; Maraninchi D; Rio B; Michallet M; Jouet JP; Milpied N
    Bone Marrow Transplant; 1990 Jun; 5(6):379-86. PubMed ID: 2088319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation.
    Heath WR; Miller JF; Sprent J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1222-4. PubMed ID: 8442095
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.
    Jansen J; Hanks S; English D; Karaffa R; Akard L
    Prog Clin Biol Res; 1992; 377():405-10. PubMed ID: 1438437
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Jansen J; Hanks S; Akard L; Martin M; Thompson J; Chang Q; Ash R; Garrett P; Figg F; English D
    Bone Marrow Transplant; 1995 Feb; 15(2):271-8. PubMed ID: 7773217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
    Schumm M; Kolb HJ; Hahn J; Beisser K; Rieber P; Günther W; Büttner M; Wilmanns W; Thierfelder S
    Prog Clin Biol Res; 1992; 377():419-25. PubMed ID: 1438440
    [No Abstract]   [Full Text] [Related]  

  • 27. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.
    Miyamura K; Barrett AJ; Kodera Y; Saito H
    Bone Marrow Transplant; 1994 Aug; 14(2):201-9. PubMed ID: 7994233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Bone Marrow Transplant; 1994 Feb; 13(2):181-5. PubMed ID: 7515741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
    Butturini A; Gale RP
    Bone Marrow Transplant; 1988 May; 3(3):185-92. PubMed ID: 3048485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.
    Kaminski E; Hows J; Man S; Brookes P; Mackinnon S; Hughes T; Avakian O; Goldman JM; Batchelor JR
    Transplantation; 1989 Oct; 48(4):608-13. PubMed ID: 2508280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation.
    Przepiorka D; Ippoliti C; Koberda J; Chan KW; Khouri IF; Fischer HE; Huh YO; Escudier SM; Seong D; Davis M
    Transplantation; 1994 Oct; 58(7):858-60. PubMed ID: 7940725
    [No Abstract]   [Full Text] [Related]  

  • 33. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transplantation of the bone marrow to patients with chronic granulocytic leukemia].
    Zduńczyk A
    Wiad Lek; 1988 Dec; 41(24):1652-7. PubMed ID: 3076730
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute graft-versus-host disease and slow marrow recovery after transplantation of OKT8-positive T cell-depleted marrow from an HLA mismatched related donor. Kanazawa Bone Marrow Transplantation Team.
    Shiobara S; Harada M; Ohtuka M; Mori T; Matsuda T; Nibu K
    Transplant Proc; 1990 Feb; 22(1):257-9. PubMed ID: 2106742
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial.
    Nimer SD; Giorgi J; Gajewski JL; Ku N; Schiller GJ; Lee K; Territo M; Ho W; Feig S; Selch M
    Transplantation; 1994 Jan; 57(1):82-7. PubMed ID: 8291119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation.
    Lamb LS; Szafer F; Henslee-Downey PJ; Walker M; King S; Godder K; Pati AR; Best R; Steinman L; Geier SS
    Exp Hematol; 1995 Dec; 23(14):1595-600. PubMed ID: 8542952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection.
    Spencer A; Brookes PA; Kaminski E; Hows JM; Szydlo RM; van Rhee F; Goldman JM; Batchelor JR
    Transplantation; 1995 May; 59(9):1302-8. PubMed ID: 7762066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.